CD8A and infection: IL-7 is a lymphocyte growth factor that has unfailingly been demonstrated to cause a dose-dependent increase in CD4 and CD8 T cells in numerous clinical trials in oncology/hematology patients and in patients with severe infections (29, 31, 32, 50, 55, 56).